Literature DB >> 22312016

Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries.

Jennifer Adjemian1, Kenneth N Olivier, Amy E Seitz, Steven M Holland, D Rebecca Prevots.   

Abstract

RATIONALE: Pulmonary nontuberculous mycobacteria (PNTM) are an important cause of morbidity among older adults in the United States, but national prevalence estimates are lacking.
OBJECTIVES: To describe the prevalence and trends of PNTM disease among adults aged 65 years or older throughout the United States.
METHODS: A nationally representative 5% sample of Medicare Part B beneficiaries was analyzed from 1997 to 2007. Demographic and medical claims data were compiled and prevalence estimates for PNTM and selected comorbidities were calculated and trends over time evaluated. Logistic regression was used to identify demographic and geographic factors associated with PNTM.
MEASUREMENTS AND MAIN RESULTS: From 1997 to 2007, the annual prevalence significantly increased from 20 to 47 cases/100,000 persons, or 8.2% per year. The period prevalence was 112 cases/100,000 persons, although prevalence was twofold higher among Asians/Pacific Islanders than among whites (228 vs. 116 cases/100,000 persons). Western states had the highest period prevalence at 149 cases/100,000 persons, with Hawaii having the highest prevalence at 396 cases/100,000 persons, followed by southeastern states, which had a period prevalence of 131 cases/100,000 persons. PNTM cases had more comorbid conditions than noncases and were 40% more likely to die than noncases. Women were 1.4 times more likely to be a PNTM case than men. Relative to whites, Asians/Pacific Islanders were twice as likely to be a case, whereas blacks were half as likely.
CONCLUSIONS: The prevalence of PNTM is increasing across all regions of the United States and among both men and women. Significant racial/ethnic and geographic differences suggest important gene-environment interactions.

Entities:  

Mesh:

Year:  2012        PMID: 22312016      PMCID: PMC3360574          DOI: 10.1164/rccm.201111-2016OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  48 in total

1.  From the Center for Disease Control and Prevention. Cigarette smoking among adults--United States, 1998.

Authors: 
Journal:  JAMA       Date:  2000-11-01       Impact factor: 56.272

2.  Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007.

Authors:  Amy E Seitz; Kenneth N Olivier; Jennifer Adjemian; Steven M Holland; D Rebecca Prevots
Journal:  Chest       Date:  2012-08       Impact factor: 9.410

3.  Epidemiology of urban tuberculosis in the United States, 2000-2007.

Authors:  Eyal Oren; Carla A Winston; Robert Pratt; Valerie A Robison; Masahiro Narita
Journal:  Am J Public Health       Date:  2011-05-12       Impact factor: 9.308

4.  Specific HLA in pulmonary MAC infection in a Japanese population.

Authors:  M Takahashi; A Ishizaka; H Nakamura; K Kobayashi; M Nakamura; M Namiki; T Sekita; S Okajima
Journal:  Am J Respir Crit Care Med       Date:  2000-07       Impact factor: 21.405

5.  From the Center for Disease Control. Isolation of nontuberculous mycobacteria in the United States, 1979.

Authors:  R C Good
Journal:  J Infect Dis       Date:  1980-11       Impact factor: 5.226

Review 6.  Nontuberculous mycobacterial disease in northern Australia: a case series and review of the literature.

Authors:  D P O'Brien; B J Currie; V L Krause
Journal:  Clin Infect Dis       Date:  2000-10-25       Impact factor: 9.079

7.  Geographic variation of racial/ethnic disparities in colorectal cancer testing among medicare enrollees.

Authors:  Thomas J Semrad; Daniel J Tancredi; Laura-Mae Baldwin; Pamela Green; Joshua J Fenton
Journal:  Cancer       Date:  2011-01-10       Impact factor: 6.860

8.  Mycobacterium kansasii infections in Western Australia (1962-1987).

Authors:  S C Pang
Journal:  Respir Med       Date:  1991-05       Impact factor: 3.415

9.  [The epidemiology of pulmonary disease caused by Mycobacterium avium complex in Japan].

Authors:  M Sakatani
Journal:  Kekkaku       Date:  1993-01

10.  Epidemiology of infection by nontuberculous mycobacteria. Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum in acid, brown-water swamps of the southeastern United States and their association with environmental variables.

Authors:  R A Kirschner; B C Parker; J O Falkinham
Journal:  Am Rev Respir Dis       Date:  1992-02
View more
  208 in total

1.  Whole-Exome Sequencing Identifies the 6q12-q16 Linkage Region and a Candidate Gene, TTK, for Pulmonary Nontuberculous Mycobacterial Disease.

Authors:  Fei Chen; Eva P Szymanski; Kenneth N Olivier; Xinyue Liu; Hervé Tettelin; Steven M Holland; Priya Duggal
Journal:  Am J Respir Crit Care Med       Date:  2017-12-15       Impact factor: 21.405

2.  Spatial clusters of nontuberculous mycobacterial lung disease in the United States.

Authors:  Jennifer Adjemian; Kenneth N Olivier; Amy E Seitz; Joseph O Falkinham; Steven M Holland; D Rebecca Prevots
Journal:  Am J Respir Crit Care Med       Date:  2012-07-05       Impact factor: 21.405

3.  Natural disasters and nontuberculous mycobacteria: a recipe for increased disease?

Authors:  Jennifer R Honda; Jon N Bernhard; Edward D Chan
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

4.  Relative risk of all-cause mortality in patients with nontuberculous mycobacterial lung disease in a US managed care population.

Authors:  Theodore K Marras; Christopher Vinnard; Quanwu Zhang; Keith Hamilton; Jennifer Adjemian; Gina Eagle; Raymond Zhang; Engels Chou; Kenneth N Olivier
Journal:  Respir Med       Date:  2018-10-22       Impact factor: 3.415

5.  In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium abscessus Complex.

Authors:  Barbara A Brown-Elliott; Richard J Wallace
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

Review 6.  Medical management of bronchiectasis.

Authors:  Anne E O'Donnell
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

7.  Opinions differ by expertise in Mycobacterium avium complex disease.

Authors:  Theodore K Marras; D Rebecca Prevots; Frances B Jamieson; Kevin L Winthrop
Journal:  Ann Am Thorac Soc       Date:  2014-01

8.  Association between Inhaled Corticosteroid Use and Pulmonary Nontuberculous Mycobacterial Infection.

Authors:  Vincent X Liu; Kevin L Winthrop; Yun Lu; Husham Sharifi; Hekmat U Nasiri; Stephen J Ruoss
Journal:  Ann Am Thorac Soc       Date:  2018-10

9.  Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk.

Authors:  Jennifer Adjemian; Kenneth N Olivier; D Rebecca Prevots
Journal:  Am J Respir Crit Care Med       Date:  2014-09-01       Impact factor: 21.405

10.  Patient-Centered Research Priorities for Pulmonary Nontuberculous Mycobacteria (NTM) Infection. An NTM Research Consortium Workshop Report.

Authors:  Emily Henkle; Timothy Aksamit; Alan Barker; Charles L Daley; David Griffith; Philip Leitman; Amy Leitman; Elisha Malanga; Theodore K Marras; Kenneth N Olivier; D Rebecca Prevots; Delia Prieto; Alexandra L Quittner; William Skach; John W Walsh; Kevin L Winthrop
Journal:  Ann Am Thorac Soc       Date:  2016-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.